2.39
0.84%
0.02
Handel nachbörslich:
2.39
Schlusskurs vom Vortag:
$2.37
Offen:
$2.37
24-Stunden-Volumen:
95,898
Relative Volume:
0.91
Marktkapitalisierung:
$103.80M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-18.38
EPS:
-0.13
Netto-Cashflow:
$10.81M
1W Leistung:
-2.45%
1M Leistung:
-0.42%
6M Leistung:
-37.92%
1J Leistung:
-44.42%
Harvard Bioscience Inc Stock (HBIO) Company Profile
Firmenname
Harvard Bioscience Inc
Sektor
Telefon
(508) 893-8999
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-03-10 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
2020-12-09 | Eingeleitet | Northland Capital | Outperform |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2019-07-08 | Herabstufung | Janney | Buy → Neutral |
2018-01-24 | Bestätigt | Janney | Buy |
2018-01-23 | Bestätigt | The Benchmark Company | Buy |
2016-11-17 | Eingeleitet | Singular Research | Buy |
2015-07-28 | Eingeleitet | The Benchmark Company | Buy |
Alle ansehen
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance
Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience - Yahoo Finance
Harvard Bioscience (HBIO) Set to Announce Earnings on Thursday - MarketBeat
Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World
Chegg, Inc. (NYSE:CHGG) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET - The Manila Times
2 Instruments Stocks to Watch From a Challenging Industry - Yahoo Finance
HBIO stock touches 52-week low at $2.31 amid market challenges - Investing.com India
Electroporation Instruments Market Analysis by Trends, - openPR
HBIO stock touches 52-week low at $2.33 amid market challenges - Investing.com Australia
Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Laboratory Centrifuge Market Innovations Investigated by Insights: Technological Advancements and Market Gr... - WhaTech
Institutional owners may take dramatic actions as Harvard Bioscience, Inc.'s (NASDAQ:HBIO) recent 12% drop adds to one-year losses - Simply Wall St
Annual Sustainability Report - Harvard University
Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m - Pharmaceutical Technology
HBIO stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa
HBIO stock touches 52-week low at $2.49 amid market challenges - Investing.com
HBIO Stock Drops Amidst Market Fluctuations - GuruFocus.com
Harvard Biosciences to Appear at Chicago Meeting - Baystreet.ca
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024 - The Manila Times
SPDR S&P Retail ETF (NYSEARCA:XRT) Stock Position Decreased by Renaissance Technologies LLC - Defense World
Compugen Ltd. (NASDAQ:CGEN) Shares Sold by Renaissance Technologies LLC - Defense World
Renaissance Technologies LLC Sells 11,300 Shares of SEACOR Marine Holdings Inc. (NYSE:SMHI) - Defense World
Microfluidics Market Innovations Investigated by Report Strategies, Forecast - WhaTech
The past three years for Harvard Bioscience (NASDAQ:HBIO) investors has not been profitable - Yahoo Finance
ACAD: 3 Healthcare Stocks Analysts Expect to Rally Over 50% - StockNews.com
Artificially Intelligent Stethoscope Market Current Scenario and Future Prospects|Eko Devices, Littmann Stethoscopes - Daily Invest News
272 Capital LP Has $4.38 Million Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat
Laboratory Colorimeter Market By Sources Analysis, Share, Trends, Size, Forecast From (2024-2034) - Third Eye News
Immunohematology Market Growth Revenue, Industry Demand Report To 2033 - WhaTech
Global Perfusion Systems Market Innovations Investigated by Trends and Outlook 2024 - WhaTech
FLO stock rated an Underperform by Exane BNP Paribas - Knox Daily
Harvard’s latest medical innovation advances 3D printed blood vessels - 3D Printing Industry
Long Term Trading Analysis for (THRD) - Stock Traders Daily
Harvard Bioscience stock hits 52-week low at $2.6 - Investing.com
United States Turbidity Instruments Market Size, Share, Trends, Growth, Analysis & Forecast - Third Eye News
Electroporator Industry – Market Insights and Growth Potential - Elektrotransports.lv
United States UV Spectrophotometer Market Size, Share, Trends, Growth, Analysis & Forecast - Third Eye News
Harvard’s Wyss Creates New Way to 3D Print Blood Vessels—Moves Closer to Artificial Organs - 3DPrint.com
Harvard Bioscience to showcase solutions for preclinical, organoid applications - TipRanks
Harvard Bioscience to Showcase Latest Solutions for - GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting - Marketscreener.com
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development - Benzinga
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology - Financial Times
Sidoti Events, LLC's Virtual September Small-Cap Conference - Yahoo Finance
Life Science And Chemical Instrumentation Market Size, Share, Trends, Demand, Forecast To 2033 - WhaTech Technology and Markets News
Electroporation Technology Market is thriving worldwide by 2031 - Elektrotransports.lv
United States Telemetry Implant Market By Application - Third Eye News
Acadian Asset Management LLC Buys 41,520 Shares of Woori Financial Group Inc. (NYSE:WF) - Defense World
Private Advisor Group LLC Purchases 14,574 Shares of Invesco S&P 500 Momentum ETF (NYSEARCA:SPMO) - Defense World
Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Harvard Bioscience Inc-Aktie (HBIO) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Green James W | Chief Executive Officer |
Jun 06 '24 |
Buy |
3.07 |
20,000 |
61,400 |
3,101,091 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):